Loading...
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)
PAM50 intrinsic breast cancer subtypes are prognostic independent of standard clinicopathologic factors. CALGB 9741 demonstrated improved recurrence-free (RFS) and overall survival (OS) with 2-weekly dose-dense (DD) versus 3-weekly therapy. A significant interaction between intrinsic subtypes and DD...
Na minha lista:
| Udgivet i: | NPJ Breast Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5501351/ https://ncbi.nlm.nih.gov/pubmed/28691057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjbcancer.2015.23 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|